Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTC: AGEEF, Germany: A9KN) announces that it has agreed to amend the terms of its previously announced “best efforts” offering (the “Offering”) of convertible debenture units (the “Convertible Debenture Units”) to lower...

Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTC: AGEEF, Germany: A9KN) is pleased to announce two key additions to our leadership team. Chad Kanner has been named Vice President of Revenue Development, alongside Gurpeet Sahani who has been appointed...

Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTC: AGEEF, Germany: A9KN) is pleased to announce its partnership to distribute the award-winning Hush™ and Gilt™ product lines through one of Southern California’s leading cannabis distributors, C4 Distro. C4 Distro’s sales...

Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTC: AGEEF, Germany: A9KN) is pleased to announce that it has filed a preliminary short form prospectus (the “Prospectus”) in connection with a “best efforts” offering (the “Offering”) of convertible debenture units...

Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTC: AGEEF, Germany: A9KN) is pleased to announce that the Company has 1 of only 52 annual state licenses issued to date and is one of the first operators in California to fully implement...

Halo Labs Inc. (“Halo” or the “Company”) (NEO:HALO, OTC:AGEEF, Germany:A9KN) is pleased to announce that the Company achieved record revenue in March 2019 of approximately US$2.8MM (CDN $3.7MM). This figure is estimated, unaudited and approximate. Not for Distribution to U.S. Newswire Servicers or...

Halo Labs Inc. (NEO: HALO, OTC: AGEEF, GERMANY: A9KN) (“Halo” or the “Company”), a cannabis extraction company that develops and manufactures quality cannabis oils and concentrates, which are the fastest growing segment in the cannabis industry, today announced that the Company’s...

Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTC: AGEEF, GERMANY: A9KN) is pleased to announce that OTC Markets Group Inc. has approved the trading of Halo Labs’ shares on the OTCQB Venture Market. The company’s shares will commence trading under the...

Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTC: AGEEF, GERMANY: A9KN) is pleased to provide a progress update on the launch of the revolutionary DabTabs™. DabTabs™ are proprietary ceramic discs that store a pre-measured single dose of either cannabis...

Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO) announces that it intends to issue common shares in the capital of the Company (“Common Shares”) in connection with a proposed acquisition to extend its 2nd Cathedral City facility by an additional 6,120...